**Question:** Treatment of choice in Wegner's granulomatosis is

A. Cyclophosphamide
B. Methotrexate
C. Leflunomide
D. Azathioprine

**Correct Answer: A. Cyclophosphamide**

**Core Concept:**
Wegner's granulomatosis, also known as Wegener's granulomatosis, is a type of systemic vasculitis characterized by inflammation of small and medium-sized blood vessels. It is a rare autoimmune disease that primarily affects the respiratory system and can lead to severe complications.

**Why the Correct Answer is Right:**
Cyclophosphamide is a cytotoxic agent and immunosuppressant used in the treatment of various autoimmune and inflammatory disorders, including Wegner's granulomatosis. It works by suppressing the immune system to prevent the excessive inflammation and tissue damage caused by the autoimmune response. In Wegner's granulomatosis, cyclophosphamide helps to reduce inflammation, control the disease progression, and prevent organ dysfunction.

**Why Each Wrong Option is Incorrect:**

**B. Methotrexate**: Methotrexate is an immunosuppressive drug primarily used in the treatment of rheumatoid arthritis and psoriasis. While it has some anti-inflammatory effects, its mechanism of action is different from cyclophosphamide, making it an inappropriate choice for treating Wegner's granulomatosis.

**C. Leflunomide**: Leflunomide is an immunosuppressive agent commonly used in the treatment of rheumatoid arthritis. Similar to methotrexate, its mechanism of action differs from cyclophosphamide, making it an incorrect choice for treating Wegner's granulomatosis.

**D. Azathioprine**: Azathioprine is an immunosuppressant used in the treatment of various autoimmune disorders, including rheumatoid arthritis and inflammatory bowel disease. While it can have some anti-inflammatory effects, its mechanism of action is different from cyclophosphamide, making it an inappropriate choice for treating Wegner's granulomatosis.

**Clinical Pearl:**
Wegner's granulomatosis is a severe inflammatory disease, and the appropriate treatment involves targeting the underlying autoimmune process rather than merely managing symptoms. Cyclophosphamide is a cytotoxic agent that directly targets the immune system, making it the most effective treatment option for this disease compared to the other choices.